The reasoning: stored injury needs a staging plan
Haemochromatosis injures by excess iron deposition. MASLD injures through metabolic steatosis and steatohepatitis. Both can have modest symptoms and nonspecific ALT changes, so the decision is not “is the patient jaundiced?” but “is there progressive fibrosis or extrahepatic harm?”